MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
批准号:
6522846
负责人:
STEVEN P STRATTON
金额:
$5.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2005-07-31
关键词:
RNase protection assay antioxidants carcinogenesis inhibitor cell cycle cell line chemoprevention confocal scanning microscopy flavonoids flow cytometry free radical oxygen gas chromatography mass spectrometry keratinocyte laboratory mouse lipid peroxides radiation protection skin neoplasms tea topical drug application transcription factor ultraviolet radiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Description) Prevention is the most efficient way
to reduce the incidence, morbidity, Nd mortality of cancer. Thus, development
of new investigators in cancer prevention research is imperative.
Steven P. Stratton, Ph.D. is a junior investigator in the field of cancer
prevention; with training in analytical chemistry, toxicology, pharmacology,
cancer therapeutics, cancer drug development, and cancer prevention
epidemiology. The mentored training supported by this award will facilitate
the development of Dr. Stratton into a fully independent investigator. This
project will be conducted at the Arizona Cancer Center, a National Cancer
Institute-designated comprehensive cancer center with an international
reputation for excellence in cancer prevention research. The proposed studies
will be performed under the aegis of the Chemoprevention of Skin Cancer
Program Project at the University of Arizona. This project will focus on skin
cancer chemoprevention mechanisms with polyphenolic derivatives of tea,
Camellia sinensis. Green tea is one of the most widely consumed beverages in
the world. Many studies both in vivo and in vitro suggest that polyphenolic
compounds present in tea inhibit skin carcinogenesis, though the mechanism of
action is still unknown. An understanding of this mechanism is crucial to the
development of chemopreventive strategies using these compounds. This project
will test the hypothesis that green tea polyphenols prevent UV
radiation-induced skin carcinogenesis by modulating reactive oxygen-mediated
alterations of normal cell function. Markers of reactive oxygen and secondary
membrane damage will be used to explore the role of tea polyphenols in
UV-induced skin cell transformation using human keratinocytes in vitro and an
in vivo mouse skin model. The specific aims of this project include analyzing
the effects of green tea polyphenols on: (1) Cell membrane lipid peroxidation
using new sensitive and specific GC/MS assays to quantify levels of oxidized
biomolecules; (2) Cell cycle progression and expression of cell cycle control
genes using flow cytometry and RNase protection techniques; (3) Regulation of
transcription factor activation using an alkaline phosphatase reporter system;
and (4) Apoptosis and translocation of relevant transcription factors using in
situ molecular imaging techniques. Changes in levels of these markers will be
used to establish links between antioxidant effects of tea polyphenols and
possible direct effects on redox-sensitive downstream events. The overall
goal of this project is to promote the development of an academic research
career in cancer prevention within a framework of molecular chemoprevention
mechanistic studies and training. Immediate goals include acquiring the
scientific and technical expertise necessary for independent investigations of
secondary cancer prevention mechanisms. Long-term career goals include
development of new methods, assays, and expertise in redox-modulated
biochemical processes; establishment of a molecular chemoprevention
laboratory; development of collaborative research programs in molecular
mechanisms of cancer prevention; and ultimately, development of
chemopreventive therapies that reduce cancer morbidity and mortality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8689936
-
项目类别:
-
资助金额:$5.18万
-
财政年份:2013
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:7944595
-
项目类别:
-
资助金额:$7.56万
-
财政年份:2009
-
负责人:STEVEN P STRATTON
-
依托单位:
Core--Drug Development
-
批准号:6991771
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2004
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6378120
-
项目类别:
-
资助金额:$11.01万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6845717
-
项目类别:
-
资助金额:$5.66万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6614436
-
项目类别:
-
资助金额:$11.64万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6192184
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6696358
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8059921
-
项目类别:
-
资助金额:$24.54万
-
财政年份:1996
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:8077350
-
项目类别:
-
资助金额:$7.92万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8504916
-
项目类别:
-
资助金额:$0.85万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention of Skin Cancer
-
批准号:8914949
-
项目类别:
-
资助金额:$26.68万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:8377812
-
项目类别:
-
资助金额:$7.12万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention of Skin Cancer
-
批准号:8689923
-
项目类别:
-
资助金额:$29.47万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:8540967
-
项目类别:
-
资助金额:$6.6万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8378073
-
项目类别:
-
资助金额:$26.86万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:8279430
-
项目类别:
-
资助金额:$3.15万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8504934
-
项目类别:
-
资助金额:$25.19万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8533368
-
项目类别:
-
资助金额:$0.67万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
海外基金